• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Logo of jvirolPermissionsJournals.ASM.orgJournalJV ArticleJournal InfoAuthorsReviewers
J Virol. Mar 1985; 53(3): 727–734.
PMCID: PMC254700

Protective effects of glycoprotein-specific monoclonal antibodies on the course of experimental mumps virus meningoencephalitis.


Newborn Syrian hamsters were challanged with an intracerebral inoculum containing 128 50% lethal doses of the Kilham strain of mumps virus and treated 24 h later with a single intraperitoneal injection of mouse monoclonal antibody. Monoclonal antibodies reactive with epitopes on the fusion glycoprotein of mumps virus could not inhibit hemagglutination or neutralize infectivity in vitro and failed to provide biologically important protection against the in vivo infection. In contrast, monoclonal antibodies reactive with epitopes on the hemagglutinin-neuraminidase glycoprotein of mumps virus inhibited hemagglutination and neutralized infectivity in vitro and protected infected animals from the otherwise lethal central nervous system virus infection. Similar protection was provided by both purified immunoglobulin and F(ab')2 fragments. Immuno-cytochemical and virological studies showed diminished virus antigen and virus titers in the brains of successfully treated animals. It appears that a topographically restricted region of the hemagglutinin-neuraminidase molecule of the Kilham strain of mumps virus is of critical importance for immune recognition by the infected host.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.8M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Images in this article

Click on the image to see a larger version.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Balachandran N, Bacchetti S, Rawls WE. Protection against lethal challenge of BALB/c mice by passive transfer of monoclonal antibodies to five glycoproteins of herpes simplex virus type 2. Infect Immun. 1982 Sep;37(3):1132–1137. [PMC free article] [PubMed]
  • Boere WA, Benaissa-Trouw BJ, Harmsen M, Kraaijeveld CA, Snippe H. Neutralizing and non-neutralizing monoclonal antibodies to the E2 glycoprotein of Semliki Forest virus can protect mice from lethal encephalitis. J Gen Virol. 1983 Jun;64(Pt 6):1405–1408. [PubMed]
  • Buchmeier MJ, Lewicki HA, Talbot PJ, Knobler RL. Murine hepatitis virus-4 (strain JHM)-induced neurologic disease is modulated in vivo by monoclonal antibody. Virology. 1984 Jan 30;132(2):261–270. [PubMed]
  • Copelovici Y, Strulovici D, Cristea AL, Tudor V, Armaşu V. Data on the efficiency of specific antimumps immunoglobulins in the prevention of mumps and of its complications. Virologie. 1979 Jul-Sep;30(3):171–177. [PubMed]
  • Dix RD, Pereira L, Baringer JR. Use of monoclonal antibody directed against herpes simplex virus glycoproteins to protect mice against acute virus-induced neurological disease. Infect Immun. 1981 Oct;34(1):192–199. [PMC free article] [PubMed]
  • Doherty PC, Gerhard W. Breakdown of the blood--cerebrospinal fluid barrier to immunoglobulin in mice injected intracerebrally with a neurotropic influenza A virus. Post-exposure treatment with monoclonal antibody promotes recovery. J Neuroimmunol. 1981 Sep;1(3):227–237. [PubMed]
  • Galfrè G, Milstein C. Preparation of monoclonal antibodies: strategies and procedures. Methods Enzymol. 1981;73(Pt B):3–46. [PubMed]
  • Griffin DE, Giffels J. Study of protein characteristics that influence entry into the cerebrospinal fluid of normal mice and mice with encephalitis. J Clin Invest. 1982 Aug;70(2):289–295. [PMC free article] [PubMed]
  • Heinz FX, Berger R, Tuma W, Kunz C. A topological and functional model of epitopes on the structural glycoprotein of tick-borne encephalitis virus defined by monoclonal antibodies. Virology. 1983 Apr 30;126(2):525–537. [PubMed]
  • Huppertz HI, Hall WW, ter Meulen V. Polypeptide composition of mumps virus. Med Microbiol Immunol. 1977 Dec 27;163(4):251–259. [PubMed]
  • Jensik SC, Silver S. Polypeptides of mumps virus. J Virol. 1976 Feb;17(2):363–373. [PMC free article] [PubMed]
  • Johnson RT, Johnson KP. Hydrocephalus following viral infection: the pathology of aqueductal stenosis developing after experimental mumps virus infection. J Neuropathol Exp Neurol. 1968 Oct;27(4):591–606. [PubMed]
  • KILHAM L, OVERMAN JR. Natural pathogenicity of mumps virus for suckling hamsters on intracerebral inoculation. J Immunol. 1953 Feb;70(2):147–151. [PubMed]
  • Lefrancois L. Protection against lethal viral infection by neutralizing and nonneutralizing monoclonal antibodies: distinct mechanisms of action in vivo. J Virol. 1984 Jul;51(1):208–214. [PMC free article] [PubMed]
  • Letchworth GJ, 3rd, Appleton JA. Passive protection of mice and sheep against bluetongue virus by a neutralizing monoclonal antibody. Infect Immun. 1983 Jan;39(1):208–212. [PMC free article] [PubMed]
  • Liddell FD. Evaluation of survival in challenge experiments. Microbiol Rev. 1978 Mar;42(1):237–249. [PMC free article] [PubMed]
  • Mathews JH, Roehrig JT. Determination of the protective epitopes on the glycoproteins of Venezuelan equine encephalomyelitis virus by passive transfer of monoclonal antibodies. J Immunol. 1982 Dec;129(6):2763–2767. [PubMed]
  • Mathews JH, Roehrig JT. Elucidation of the topography and determination of the protective epitopes on the E glycoprotein of Saint Louis encephalitis virus by passive transfer with monoclonal antibodies. J Immunol. 1984 Mar;132(3):1533–1537. [PubMed]
  • McCarthy M, Johnson RT. A comparison of the structural polypeptides of five strains of mumps virus. J Gen Virol. 1980 Jan;46(1):15–27. [PubMed]
  • McCarthy M, Jubelt B, Fay DB, Johnson RT. Comparative studies of five strains of mumps virus in vitro and in neonatal hamsters: evaluation of growth, cytopathogenicity, and neurovirulence. J Med Virol. 1980;5(1):1–15. [PubMed]
  • Merz DC, Server AC, Waxham MN, Wolinsky JS. Biosynthesis of mumps virus F glycoprotein: non-fusing strains efficiently cleave the F glycoprotein precursor. J Gen Virol. 1983 Jul;64(Pt 7):1457–1467. [PubMed]
  • Naruse H, Nagai Y, Yoshida T, Hamaguchi M, Matsumoto T, Isomura S, Suzuki S. The polypeptides of mumps virus and their synthesis in infected chick embryo cells. Virology. 1981 Jul 15;112(1):119–130. [PubMed]
  • Orvell C. Immunological properties of purified mumps virus glycoproteins. J Gen Virol. 1978 Dec;41(3):517–526. [PubMed]
  • Orvell C. The reactions of monoclonal antibodies with structural proteins of mumps virus. J Immunol. 1984 May;132(5):2622–2629. [PubMed]
  • Orvell C, Grandien M. The effects of monoclonal antibodies on biologic activities of structural proteins of Sendai virus. J Immunol. 1982 Dec;129(6):2779–2787. [PubMed]
  • Parham P. On the fragmentation of monoclonal IgG1, IgG2a, and IgG2b from BALB/c mice. J Immunol. 1983 Dec;131(6):2895–2902. [PubMed]
  • Rammohan KW, McFarland HF, McFarlin DE. Induction of subacute murine measles encephalitis by monoclonal antibody to virus haemagglutinin. Nature. 1981 Apr 16;290(5807):588–589. [PubMed]
  • Rector JT, Lausch RN, Oakes JE. Use of monoclonal antibodies for analysis of antibody-dependent immunity to ocular herpes simplex virus type 1 infection. Infect Immun. 1982 Oct;38(1):168–174. [PMC free article] [PubMed]
  • Schmaljohn AL, Johnson ED, Dalrymple JM, Cole GA. Non-neutralizing monoclonal antibodies can prevent lethal alphavirus encephalitis. Nature. 1982 May 6;297(5861):70–72. [PubMed]
  • Server AC, Merz DC, Waxham MN, Wolinsky JS. Differentiation of mumps virus strains with monoclonal antibody to the HN glycoprotein. Infect Immun. 1982 Jan;35(1):179–186. [PMC free article] [PubMed]
  • Spiegelberg HL. Biological activities of immunoglobulins of different classes and subclasses. Adv Immunol. 1974;19(0):259–294. [PubMed]
  • Waxham MN, Wolinsky JS. Immunochemical identification of rubella virus hemagglutinin. Virology. 1983 Apr 15;126(1):194–203. [PubMed]
  • Wolinsky JS. Mumps virus-induced hydrocephalus in hamsters. Ultrastructure of the chronic infection. Lab Invest. 1977 Sep;37(3):229–236. [PubMed]
  • Wolinsky JS, Baringer JR, Margolis G, Kilham L. Ultrastructure of mumps virus replication in newborn hamster central nervous system. Lab Invest. 1974 Oct;31(4):403–412. [PubMed]
  • Wolinsky JS, Klassen T, Baringer JR. Persistence of neuroadapted mumps virus in brains of newborn hamsters after intraperitoneal inoculation. J Infect Dis. 1976 Mar;133(3):260–267. [PubMed]
  • Wolinsky JS, Waxham MN, Hess JL, Townsend JJ, Baringer JR. Immunochemical features of a case of progressive rubella panencephalitis. Clin Exp Immunol. 1982 May;48(2):359–366. [PMC free article] [PubMed]

Articles from Journal of Virology are provided here courtesy of American Society for Microbiology (ASM)


Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...


Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...